What role do innovative trial designs and technologies play in clinical trials?

• A. They may enable the inclusion of a wider and more diverse population of participants.
• B. They always complicate trials and hinder safety assessment.
• C. They replace the need for ethical review.
• D. They guarantee results with no additional risk.

Answer: (A)

Innovative trial designs and technologies broaden who can participate and how data are collected. By enabling decentralized or hybrid trials, digital consent, remote monitoring, and flexible visit schedules, trials become more accessible to people who live far away, have mobility or time constraints, or face other barriers. This can lead to a wider, more diverse participant pool, including individuals from various ages, geographic areas, and backgrounds, which helps make study results more generalizable and applicable to real-world populations. These approaches can also support ongoing safety monitoring and more efficient decision-making during a trial.

The other statements aren’t accurate reflections of these advances: innovative designs don’t inherently complicate trials and hinder safety assessment; ethical review remains required and central despite new methods; and nothing about these designs guarantees results or eliminates risk.